laseraway semaglutide Issuu Semaglutide as a MASH Treatment:

Chauhan, N

For most people, the real challenge isnt losing weight its keeping it off

One in three women undergoing axillary lymph node dissection and radiotherapy will develop this incurable and disabling disease ( As far back as 1957 studies have shown that obesity can increase the risk of secondary lymphedema ( Glucagon-like peptide 1 receptor agonists (GLP-1RAs) were originally brought to market as treatments for diabetes, and were noted to induce weight loss ( Although weight loss has been reported to be beneficial in the treatment of lymphedema, no studies to date have examined the use of GLP-1RAs for the treatment of secondary lymphedema

Interestingly, a recent study showed that oral supplementation of NR altered the intestinal microbial composition in rats and mice but not humans 63 , highlighting the need for further studies on this matter to assess the impact of NAD + metabolism modulation by the microbiome on health outcomes

Snchez-Bretao A et al